tm logo
RENOVARE REGENERATIVE MEDICINE
Live/Registered
REGISTERED

on 26 Nov 2019

Last Applicant/ Owned by

2100 West Loop South, Suite 1200

Houston

TX

77027

Serial Number

88286268 filed on 01st Feb 2019

Registration Number

5918476 registered on 26th Nov 2019

in the Principal Register

Correspondent Address

Robert J. Ward

ROBERT J. WARD FOLEY & LARDNER LLP

2021 MCKINNEY AVENUE, SUITE 1600

DALLAS, TX 75201

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RENOVARE REGENERATIVE MEDICINE

Medical services, namely, regenerative therapy treatments for musculoskeletal conditions and for systemic conditions

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services, namely, regenerative therapy treatments for musculoskeletal conditions and for systemic conditions


First Use Date in General

04th Feb 2019

First Use Date in Commerce

04th Feb 2019

Mark Details


Serial Number

No 88286268

Mark Type

No Service Mark

Attorney Docket Number

No 121898-3000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

26.05.09 -

Triangles made of geometric figures, objects, humans, plants or animals

26.05.28 -

Miscellaneous designs with overall triangular shape

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
26th Nov 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
26th Nov 2019REGISTERED-PRINCIPAL REGISTER
10th Sep 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Sep 2019PUBLISHED FOR OPPOSITION
21st Aug 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08th Aug 2019ASSIGNED TO LIE
30th Jul 2019APPROVED FOR PUB - PRINCIPAL REGISTER
26th Jul 2019TEAS/EMAIL CORRESPONDENCE ENTERED
25th Jul 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
25th Jul 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED